Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.5K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.7K
The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.4K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

842
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
842
Atypical Pneumonia01:14

Atypical Pneumonia

84
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
84
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Etiologic studies of trachoma on Taiwan.

Report (U.S. Naval Medical Research Laboratory)·2014
Same author

Studies of encephalitis on Taiwan. VI. Infections in American servicemen on Taiwan and Okinawa.

Report (U.S. Naval Medical Research Laboratory)·2014
Same author

Studies of encephalitis on Taiwan. VI. Infections in American servicemen on Taiwan and Okinawa.

Report (U.S. Naval Medical Research Laboratory)·2014
Same author

Encephalitis on Taiwan. I. Introduction and epidemiology.

Report (U.S. Naval Medical Research Laboratory)·2014
Same author

Bacterial conjunctivitis caused by a base eye ointment used as a placebo.

Report (U.S. Naval Medical Research Laboratory)·2014
Same author

Complement fixation test for diagnosis of trachoma in India.

Report (U.S. Naval Medical Research Laboratory)·2014

Related Experiment Video

Updated: May 5, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 24, 2013

12.4K

Chlamydia pneumoniae, strain TWAR pneumonia.

J T Grayston1

  • 1Department of Epidemiology, University of Washington, Seattle 98195.

Annual Review of Medicine
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Chlamydia pneumoniae, strain TWAR, a newly identified Chlamydia species, causes respiratory infections like pneumonia. Effective treatment necessitates high-dose, long-term antibiotics such as tetracycline or erythromycin.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 18, 2014

23.0K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

17.4K

Related Experiment Videos

Last Updated: May 5, 2026

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 24, 2013

12.4K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 18, 2014

23.0K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

17.4K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Chlamydia pneumoniae, strain TWAR, is a recently identified species within the Chlamydia genus.
  • This bacterium is a significant etiological agent responsible for various acute respiratory tract infections.

Purpose of the Study:

  • To highlight the clinical significance of Chlamydia pneumoniae, strain TWAR.
  • To inform on transmission routes and effective therapeutic strategies for infections caused by this pathogen.

Main Methods:

  • Literature review on Chlamydia pneumoniae, strain TWAR.
  • Analysis of clinical data regarding respiratory infections.
  • Evaluation of antibiotic efficacy.

Main Results:

  • Chlamydia pneumoniae, strain TWAR, is implicated in pneumonia, bronchitis, and sinusitis.
  • The pathogen is transmitted via the respiratory route.
  • High-dosage and prolonged courses of tetracycline or erythromycin are required for successful treatment.

Conclusions:

  • Chlamydia pneumoniae, strain TWAR, represents a distinct and clinically relevant species.
  • Understanding its transmission and treatment is crucial for managing respiratory infections.
  • Therapeutic regimens must be optimized for dosage and duration to ensure eradication.